Melanotan II has no approved label, so there is no validated dose. The figures circulated online come from anecdotal gray-market use, not a prescribing guideline or clinical trial. We describe what is claimed only so the uncertainty is clear, not as a protocol to follow.[1]
Reviewed for accuracy · Last reviewed July 8, 2026There is no approved dose for Melanotan II. Gray-market use is described as a subcutaneous "loading" phase of small daily injections until a desired tan appears, then less frequent "maintenance" injections, but these figures are anecdotal, unvalidated, and vary widely between sources:
Gray-market accounts usually describe a subcutaneous "loading" phase of small daily injections until a tan develops, followed by an occasional "maintenance" injection. The amounts quoted vary widely between sources and are not standardized or verified. Because Melanotan II is unapproved, products may be mislabeled, underdosed, overdosed, or contaminated, so even the stated amount may not reflect what is in a vial.
There is no titration table here because presenting a precise schedule would imply a validated dose that does not exist. Any dose of an unapproved injectable peptide carries the documented risks covered on the side effects page, including priapism and changes to moles.
This page is an independent educational reference and is not medical advice, and does not indicate any approval status for any use. Melanotan II is not approved by any regulator. Talk to a doctor before considering any compound.